Fabrinet vs. DNA X, Inc. Common Stock
DNA X, Inc. Common Stock (SONM) comes out ahead, leading on 5 of 8 compared factors.
Size & Scale
| FN | SONM | |
|---|---|---|
| Market Cap | $13.65 billion | $4.49 million |
| Revenue (TTM) | $4.64 billion | $-27,911,000 |
| Net Income (TTM) | $473.03 million | $-8,547,000 |
FN leads on 3 of 3 size & scale factors.
Valuation
| FN | SONM | |
|---|---|---|
| P/E Ratio | 29.62 | — |
| Price / Book | 5.56 | -3.65 |
| Price / Sales | 2.94 | -0.16 |
SONM leads on 2 of 2 valuation factors.
Profitability
| FN | SONM | |
|---|---|---|
| Net Margin | 10.19% | 30.62% |
| Return on Equity | 19.27% | 693.75% |
SONM leads on 2 of 2 profitability factors.
Risk & Sentiment
| FN | SONM | |
|---|---|---|
| Short Interest | 9.50% | 0.85% |
SONM leads on 1 of 1 risk & sentiment factors.
Dig deeper: FN overview, FN financials, SONM overview, SONM financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.